Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for a total equity value of ~$10B, adding treatments for rare hormonal diseases to its portfolio
Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for a total equity value of ~$10B, adding treatments for rare hormonal diseases to its portfolio | Spyke
No replies yet